Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

SELL
$256.56 - $292.34 $520,303 - $592,865
-2,028 Reduced 88.37%
267 $74,000
Q4 2022

Jan 26, 2023

SELL
$252.44 - $306.72 $43,419 - $52,755
-172 Reduced 6.97%
2,295 $0
Q3 2022

Oct 31, 2022

BUY
$194.69 - $268.46 $166,654 - $229,801
856 Added 53.13%
2,467 $659,000
Q2 2022

Jul 26, 2022

BUY
$187.54 - $223.02 $140,842 - $167,488
751 Added 87.33%
1,611 $329,000
Q1 2022

Apr 27, 2022

SELL
$193.77 - $244.14 $6,200 - $7,812
-32 Reduced 3.59%
860 $181,000
Q4 2021

Jan 31, 2022

SELL
$223.92 - $287.77 $435,972 - $560,288
-1,947 Reduced 68.58%
892 $214,000
Q3 2021

Nov 03, 2021

SELL
$282.99 - $369.05 $602,768 - $786,076
-2,130 Reduced 42.87%
2,839 $803,000
Q2 2021

Jul 30, 2021

SELL
$259.0 - $414.71 $271,432 - $434,616
-1,048 Reduced 17.42%
4,969 $1.72 Million
Q1 2021

Apr 29, 2021

BUY
$242.95 - $284.63 $499,748 - $585,483
2,057 Added 51.94%
6,017 $1.68 Million
Q4 2020

Jan 28, 2021

SELL
$236.26 - $355.63 $505,360 - $760,692
-2,139 Reduced 35.07%
3,960 $970,000
Q3 2020

Oct 29, 2020

SELL
$264.77 - $305.71 $321,960 - $371,743
-1,216 Reduced 16.62%
6,099 $1.73 Million
Q2 2020

Jul 24, 2020

SELL
$258.66 - $342.55 $41,644 - $55,150
-161 Reduced 2.15%
7,315 $1.96 Million
Q1 2020

Apr 29, 2020

BUY
$268.85 - $341.04 $438,225 - $555,895
1,630 Added 27.88%
7,476 $2.37 Million
Q4 2019

Jan 27, 2020

BUY
$220.06 - $304.07 $61,176 - $84,531
278 Added 4.99%
5,846 $1.74 Million
Q3 2019

Oct 28, 2019

SELL
$217.44 - $243.88 $217,005 - $243,392
-998 Reduced 15.2%
5,568 $1.3 Million
Q2 2019

Jul 30, 2019

SELL
$219.29 - $241.72 $1.07 Million - $1.18 Million
-4,868 Reduced 42.57%
6,566 $1.54 Million
Q1 2019

Apr 30, 2019

SELL
$216.71 - $338.96 $655,764 - $1.03 Million
-3,026 Reduced 20.93%
11,434 $2.7 Million
Q4 2018

Feb 01, 2019

SELL
$278.5 - $352.75 $221,407 - $280,436
-795 Reduced 5.21%
14,460 $4.35 Million
Q3 2018

Nov 05, 2018

BUY
$293.51 - $383.83 $978,855 - $1.28 Million
3,335 Added 27.98%
15,255 $5.39 Million
Q2 2018

Jul 30, 2018

SELL
$257.52 - $306.91 $360,270 - $429,367
-1,399 Reduced 10.5%
11,920 $3.46 Million
Q1 2018

May 02, 2018

SELL
$260.13 - $367.91 $202,641 - $286,601
-779 Reduced 5.53%
13,319 $3.65 Million
Q4 2017

Jan 31, 2018

BUY
$307.64 - $344.58 $3.99 Million - $4.46 Million
12,954 Added 1132.34%
14,098 $4.49 Million
Q3 2017

Oct 31, 2017

BUY
$281.15 - $329.69 $321,635 - $377,165
1,144
1,144 $358,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.